Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| CRMD | CORMEDIX INC | $876.97M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TGTX | TG THERAPEUTICS INC | $4.46B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CORT | CORCEPT THERAPEUTICS INC | $7.56B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GYRE | GYRE THERAPEUTICS INC | $783.99M | N/A | 0.00% | $20.0200 | N/A | N/A | 0 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $2.47B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRYS | KRYSTAL BIOTECH INC | $4.35B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $7.87B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARGX | ARGENX SE | $39.91B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RPRX | ROYALTY PHARMA PLC | $21.20B | 2.39% | 37.20% | $0.2200 | $0.87 | 53% | 0 | 2025-09-10 | |
| INVA | INNOVIVA INC | $1.32B | N/A | 0.00% | $0.2500 | N/A | N/A | 0 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.62B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCEL | VERICEL CORP | $1.83B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXEL | EXELIXIS INC | $10.31B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.12B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INCY | INCYTE CORP | $16.97B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ADMA | ADMA BIOLOGICS INC | $4.05B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MNKD | MANNKIND CORP | $1.14B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ATRA | ATARA BIOTHERAPEUTICS INC | $86.31M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MDXG | MIMEDX GROUP INC | $1.05B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TECH | BIO-TECHNE CORP | $8.40B | 0.60% | 38.60% | $0.0800 | $0.32 | 13% | 1 | 2025-08-18 | 2025-08-29 |
| VCYT | VERACYTE INC | $2.37B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NVO | NOVO NORDISK A S | $234.01B | 2.10% | 41.40% | $1.0992 | $1.10 | 48% | 9 | 2025-08-18 | 2025-08-26 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.05B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NAGE | NIAGEN BIOSCIENCE INC | $799.12M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.48B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GMAB | GENMAB A | $14.95B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $100.71B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.